Moreover, both bioluminescence imaging and tumor specimen analysis revealed that tumor volume and weight were decreased by si-β-catenin or si-c-Myc in RGS19-overexpressing cells in vivo (Fig. 5g–i). The gene discussed is MYC; the disease is neoplasm.